• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘中的气道重塑

Airway remodeling in asthma.

作者信息

Woodruff Prescott G, Fahy John V

机构信息

Department of Medicine, University of California at San Francisco, 94143, USA.

出版信息

Semin Respir Crit Care Med. 2002 Aug;23(4):361-7. doi: 10.1055/s-2002-34331.

DOI:10.1055/s-2002-34331
PMID:16088629
Abstract

Airway remodeling is a summary term for the pathological changes that occur in airway structure in allergic or suppurative airway diseases. Characteristic changes of airway remodeling in asthma include goblet cell hyperplasia, deposition of collagens in the basement membrane zone, increased size and number of microvessels in the submucosa, hyperplasia and hypertrophy of airway smooth muscle, and hypertrophy of submucosal glands. Some of these changes, such as goblet cell hyperplasia and subepithelial collagen deposition, are present even in mild asthma; other changes such as increases in airway smooth muscle and gland volume appear to be more characteristic of severe asthma. Airway narrowing, airway hyperresponsiveness, and mucus hypersecretion are all functional consequences of airway remodeling leading to clinical manifestations such as dyspnea, wheeze, sputum production, and susceptibility to asthma exacerbations. Noninvasive measures of remodeling are lacking, and monitoring the effects of treatment on remodeling has been difficult. For this reason relatively little is known about the effects of current asthma treatments on airway remodeling. As mechanisms of airway remodeling are developed, it is hoped that novel therapeutic targets will be identified. Treatments specifically targeting mediators of remodeling hold promise as treatments that could modify disease progression in asthma.

摘要

气道重塑是过敏性或化脓性气道疾病中气道结构发生的病理变化的统称。哮喘气道重塑的特征性变化包括杯状细胞增生、基底膜区胶原蛋白沉积、黏膜下层微血管大小和数量增加、气道平滑肌增生和肥大以及黏膜下腺肥大。其中一些变化,如杯状细胞增生和上皮下胶原沉积,即使在轻度哮喘中也存在;其他变化,如气道平滑肌和腺体体积增加,似乎更具重度哮喘的特征。气道狭窄、气道高反应性和黏液分泌过多都是气道重塑的功能后果,导致呼吸困难、喘息、咳痰和哮喘加重易感性等临床表现。目前缺乏气道重塑的非侵入性测量方法,监测治疗对气道重塑的效果也很困难。因此,对于目前哮喘治疗对气道重塑的影响了解相对较少。随着气道重塑机制的深入研究,有望确定新的治疗靶点。专门针对重塑介质的治疗方法有望成为改变哮喘疾病进展的治疗手段。

相似文献

1
Airway remodeling in asthma.哮喘中的气道重塑
Semin Respir Crit Care Med. 2002 Aug;23(4):361-7. doi: 10.1055/s-2002-34331.
2
Structural changes in the airways in asthma: observations and consequences.哮喘气道的结构变化:观察结果与影响
Clin Sci (Lond). 2005 Jun;108(6):463-77. doi: 10.1042/CS20040342.
3
Review: Pharmacological treatment of airway remodeling: inhaled corticosteroids or antileukotrienes?综述:气道重塑的药物治疗:吸入性糖皮质激素还是白三烯调节剂?
Ann Clin Lab Sci. 2004 Spring;34(2):138-42.
4
[Airway remodeling in asthma: clinical and functional correlates].[哮喘中的气道重塑:临床与功能相关性]
Med Sci (Paris). 2011 Nov;27(11):959-65. doi: 10.1051/medsci/20112711011. Epub 2011 Nov 30.
5
Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling-.哮喘中的气道重塑与不可逆气流受限——气道中的细胞外基质沉积及重塑的可能治疗方法——
Allergol Int. 2007 Dec;56(4):321-9. doi: 10.2332/allergolint.R-07-151. Epub 2007 Nov 1.
6
Airway mucus hypersecretion in asthma: an undervalued pathology?哮喘中的气道黏液高分泌:一种被低估的病理状态?
Curr Opin Pharmacol. 2004 Jun;4(3):241-50. doi: 10.1016/j.coph.2004.01.011.
7
[Airway remodeling in asthma: mechanisms and therapeutic perspectives].[哮喘中的气道重塑:机制与治疗前景]
Med Sci (Paris). 2003 Mar;19(3):319-26. doi: 10.1051/medsci/2003193319.
8
Remodeling in asthma.哮喘中的重塑
Proc Am Thorac Soc. 2009 May 1;6(3):301-5. doi: 10.1513/pats.200808-089RM.
9
Remodeling of the airway epithelium in asthma.哮喘中气道上皮的重塑
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S46-51. doi: 10.1164/ajrccm.164.supplement_2.2106066.
10
Asthma therapy and airway remodeling.哮喘治疗与气道重塑
J Allergy Clin Immunol. 2007 Nov;120(5):997-1009; quiz 1010-1. doi: 10.1016/j.jaci.2007.06.031. Epub 2007 Aug 6.

引用本文的文献

1
Studies on nanoprotein vaccine alleviating symptoms of mice allergic to rFel d 1.纳米蛋白疫苗缓解对重组猫源Fel d 1过敏小鼠症状的研究。
Front Immunol. 2025 May 26;16:1524929. doi: 10.3389/fimmu.2025.1524929. eCollection 2025.
2
PAR-2-activated secretion by airway gland serous cells: role for CFTR and inhibition by .气道腺泡浆液细胞中 PAR-2 激活的分泌作用:CFTR 的作用及 的抑制作用
Am J Physiol Lung Cell Mol Physiol. 2021 May 1;320(5):L845-L879. doi: 10.1152/ajplung.00411.2020. Epub 2021 Mar 3.
3
Paucigranulocytic asthma: Uncoupling of airway obstruction from inflammation.
少粒细胞性哮喘:气道阻塞与炎症脱耦联。
J Allergy Clin Immunol. 2019 Apr;143(4):1287-1294. doi: 10.1016/j.jaci.2018.06.008. Epub 2018 Jun 19.
4
The Correlation between FSTL1 Expression and Airway Remodeling in Asthmatics.哮喘患者中 FSTL1 表达与气道重塑的相关性。
Mediators Inflamm. 2017;2017:7918472. doi: 10.1155/2017/7918472. Epub 2017 Aug 3.
5
Bronchial thermoplasty: implementing best practice in the era of cost containment.支气管热成形术:在成本控制时代实施最佳实践。
J Asthma Allergy. 2017 Jul 26;10:225-230. doi: 10.2147/JAA.S135291. eCollection 2017.
6
Type 2 inflammation in asthma--present in most, absent in many.哮喘中的2型炎症——多数存在,许多不存在。
Nat Rev Immunol. 2015 Jan;15(1):57-65. doi: 10.1038/nri3786.
7
Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma.上皮细胞衍生的骨膜蛋白在哮喘中 TGF-β激活、胶原产生和胶原凝胶弹性中的作用。
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14170-5. doi: 10.1073/pnas.1009426107. Epub 2010 Jul 26.
8
Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection.白细胞介素-13 诱导的粘液化生增加了人呼吸道上皮细胞对鼻病毒感染的易感性。
Am J Respir Cell Mol Biol. 2010 Dec;43(6):652-61. doi: 10.1165/rcmb.2009-0244OC. Epub 2010 Jan 15.
9
Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.白细胞介素-4、白细胞介素-13、信号转导和转录激活因子6与过敏性哮喘
Curr Mol Med. 2008 Aug;8(5):384-92. doi: 10.2174/156652408785161032.
10
Following the TRAIL to apoptosis.追踪细胞凋亡之路。
Immunol Res. 2006;35(3):249-62. doi: 10.1385/IR:35:3:249.